search icon
  • Print
  • ShareThis
  • Text Size
  • HIVMA Logo
  • In Memoriam Mark Wainberg (1945-2017)


    Statement from HIV Medicine Association Chair Wendy Armstrong, MD, FIDSA

    The HIV community is deeply saddened to learn of the tragic loss of Mark Wainberg this week. Mark was known to all of us as an innovator in the field of HIV and, in particular, in drug development. Dr. Wainberg was the head of AIDS Research at the Lady Davis Institute for Medical Research, Director of the McGill University AIDS Center and Professor of Medicine, Microbiology and Immunology at McGill University in Montreal, Canada. He consistently pushed the boundaries of conventional thought whether he was advocating for new treatment paradigms or universal and equitable access to medications for all those with living with HIV across the globe. As President of the International AIDS Society, Mark was an early proponent of holding scientific meetings where the epidemic was most severe, often in the developing world, a practice that is now usual. He strongly opposed AIDS denialism and was vocal in his opposition of former South African President Thabo Mbeki’s damaging stance and policies. At the time of his death, he remained an active investigator focusing on HIV cure strategies. His commitment to science and social justice will continue to be a motivating force and an inspiration to the global HIV community. He will be sorely missed.


    The HIV Medicine Association (HIVMA) is the professional home for more than 5,000 physicians, scientists, and other health care professionals dedicated to the field of HIV/AIDS. Nested within the Infectious Diseases Society of America (IDSA), HIVMA promotes quality in HIV care and advocates policies that ensure a comprehensive and humane response to the AIDS pandemic informed by science and social justice. For more information, visit


| IDSA | Contact Us

© Copyright HIVMA 2018 HIV Medicine Association

Full Site Mobile Site